Neuronetics Files Prospectus To Offer Up To 20.7M Shares Of Common Stock By The Selling Stockholders

Neuronetics has filed a prospectus with the SEC to offer up to 20.7 million shares of common stock by selling stockholders. This move may impact the company's stock ticker STIM, as it indicates potential changes in ownership and liquidity in the market.